Development of a guidance for including patient-reported outcomes (PROs) in post-approval clinical trials of oncology drugs for comparative effectiveness research (CER).

Category Systematic review
JournalJournal of Clinical Oncology
Year 2011
This article has no abstract
Epistemonikos ID: cd1f5796a06884f256399ba421b4fec44de39f81
First added on: Feb 04, 2025